3. Table of Adverse Events Results.
Study |
Protocolized weaning n/N (%) |
Non‐protocolized weaning n/N (%) |
Risk Ratio | 95% CI | P‐value |
PICU Mortality | |||||
Foronda 2011 | 23/155 (14.8) | 15/139 (10.8) | 1.44 | 0.72 to 2.89 | 0.30 |
Jouvet 2013 | 1/15 (6.7) | 0/15 (0.0) | 3.0 | 0.13 to 68.26 | NR |
Reintubation | |||||
Foronda 2011 | 15/134 (11.2) | 18/126 (14.3) | 0.78 | 0.41 to 1.49 | 0.45 |
Jouvet 2013 | 2/15 (13.3) | 1/15 (6.7) | 2.0 | 0.2 to 19.78 | NR |
Maloney 2007 | 2/15 (13.3) | 3/16 (12.5) | 0.71 | 0.14 to 3.68 | 1.0 |
Self‐extubation | |||||
Foronda 2011 | 3/134 (2.2) | 8/126 (6.3) | 0.35 | 0.1 to 1.3 | 0.10 |
Jouvet 2013 | 1/15 (6.7) | 0/15 (0.0) | 3.0 | 0.13 to 68.26 | NR |
Maloney 2007 | 0 | 0 | NE | NE | NE |
Non‐invasive ventilation post extubation | |||||
Foronda 2011 | 29/134 (21.6) | 39/126 (31.0) | 0.7 | 0.46 to 1.06 | 0.09 |
Jouvet 2013 | 1/15 (6.7) | 2/15 (13.3) | 0.5 | 0.05 to 4.94 | NR |
Ventilator‐associated pneumonia | |||||
Foronda 2011 | 9/123 (6.7) | 12/126 (9.5) | 0.77 | 0.34 to 1.76 | 0.41 |
Prolonged MV | |||||
Jouvet 2013 | 0/15 (0.0) | 2/15 (13.3) | 0.20 | 0.01 to 3.85 | NR |
NE, not estimable; NR, not reported.